Deutsche Bank Ag\ Cytek Biosciences, Inc. Transaction History

Deutsche Bank Ag\

$287 Billion
Q3 2025

A detailed history of Deutsche Bank Ag\ transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 89,020 shares of CTKB stock, worth $489,610. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,020

Previous 77,048 15.54%

Holding current value

$489,610

Previous $261,000 18.01%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$3.1 - $4.17 $37,113 - $49,923	11,972 Added 15.54%	89,020 $308,000
Q2 2025 Aug 12, 2025	SELL	$2.42 - $3.99 $40,912 - $67,454	-16,906 Reduced 17.99%	77,048 $261,000
Q1 2025 May 09, 2025	SELL	$4.0 - $7.26 $36,912 - $66,995	-9,228 Reduced 8.94%	93,954 $376,000
Q4 2024 Jun 30, 2025	BUY	$4.7 - $7.4 $43,371 - $68,287	9,228 Added 9.82%	103,182 $669,000
Q4 2024 Feb 14, 2025	BUY	$4.7 - $7.4 $171,747 - $270,410	36,542 Added 54.83%	103,182 $669,000

Q3 2024 Jun 26, 2025	SELL	$4.73 - $6.73 $129,195 - $183,823	-27,314 Reduced 29.07%	66,640 $369,000
Q3 2024 Nov 13, 2024	BUY	$4.73 - $6.73 $45,999 - $65,449	9,725 Added 17.09%	66,640 $369,000
Q2 2024 Jun 12, 2025	SELL	$5.3 - $6.91 $196,306 - $255,939	-37,039 Reduced 39.42%	56,915 $317,000
Q2 2024 Aug 14, 2024	SELL	$5.3 - $6.91 $54,277 - $70,765	-10,241 Reduced 15.25%	56,915 $317,000
Q1 2024 Jun 02, 2025	SELL	$6.29 - $9.15 $168,559 - $245,201	-26,798 Reduced 28.52%	67,156 $450,000
Q1 2024 May 15, 2024	BUY	$6.29 - $9.15 $9,762 - $14,200	1,552 Added 2.37%	67,156 $450,000
Q4 2023 Feb 14, 2024	SELL	$4.1 - $9.51 $5,157 - $11,963	-1,258 Reduced 1.88%	65,604 $598,000
Q3 2023 Nov 09, 2023	BUY	$5.52 - $9.5 $87,276 - $150,204	15,811 Added 30.97%	66,862 $369,000
Q2 2023 Aug 14, 2023	SELL	$6.69 - $11.99 $160,847 - $288,275	-24,043 Reduced 32.02%	51,051 $435,000
Q1 2023 May 15, 2023	BUY	$8.44 - $13.47 $157,296 - $251,040	18,637 Added 33.01%	75,094 $690,000
Q4 2022 Feb 13, 2023	BUY	$9.71 - $15.86 $46,510 - $75,969	4,790 Added 9.27%	56,457 $576,000
Q3 2022 Nov 14, 2022	SELL	$10.96 - $15.45 $62,746 - $88,451	-5,725 Reduced 9.98%	51,667 $761,000
Q2 2022 Aug 11, 2022	BUY	$7.41 - $11.56 $20,807 - $32,460	2,808 Added 5.14%	57,392 $616,000
Q1 2022 May 13, 2022	BUY	$9.89 - $17.25 $436,791 - $761,846	44,165 Added 423.89%	54,584 $588,000
Q4 2021 Feb 11, 2022	BUY	$16.14 - $25.04 $8,764 - $13,596	543 Added 5.5%	10,419 $170,000
Q3 2021 Nov 04, 2021	BUY	$17.52 - $27.93 $173,027 - $275,836	9,876 New	9,876 $212,000

Others Institutions Holding CTKB

# of Institutions

151

Shares Held

73M

Call Options Held

Put Options Held

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $740M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account